APA (7th ed.) Citation

Krämer, I., König, L., Hassel, J. C., Luft, T., Hegenbart, U., Eichkorn, T., . . . Dreger, P. (2026). Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma. Bone marrow transplantation. https://doi.org/10.1038/s41409-025-02796-8

Chicago Style (17th ed.) Citation

Krämer, Isabelle, Laila König, Jessica C. Hassel, Thomas Luft, Ute Hegenbart, Tanja Eichkorn, Peter Stadtherr, Carsten Müller-Tidow, and Peter Dreger. "Intermediate-dose TBI/fludarabine Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Cutaneous T-cell Lymphoma." Bone Marrow Transplantation 2026. https://doi.org/10.1038/s41409-025-02796-8.

MLA (9th ed.) Citation

Krämer, Isabelle, et al. "Intermediate-dose TBI/fludarabine Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Cutaneous T-cell Lymphoma." Bone Marrow Transplantation, 2026, https://doi.org/10.1038/s41409-025-02796-8.